Mega Lifesciences (Thailand) Analysis
| MEGA Stock | THB 35.00 0.25 0.72% |
Mega Lifesciences Public is overvalued with Real Value of 29.88 and Hype Value of 34.75. The main objective of Mega Lifesciences stock analysis is to determine its intrinsic value, which is an estimate of what Mega Lifesciences Public is worth, separate from its market price. There are two main types of Mega Lifesciences' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Mega Lifesciences' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Mega Lifesciences' stock to identify patterns and trends that may indicate its future price movements.
The Mega Lifesciences stock is traded in Thailand on Thailand Exchange, with the market opening at 10:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Thailand.
Mega |
Mega Stock Analysis Notes
About 61.0% of the company outstanding shares are owned by corporate insiders. The book value of Mega Lifesciences was now reported as 9.78. The company last dividend was issued on the 24th of August 2022. Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures, markets, and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast moving consumer goods. Mega Lifesciences Public Company Limited is a subsidiary of Unistretch Limited. MEGA LIFESCIENCES operates under Drug Manufacturers - Major classification in Thailand and is traded on Stock Exchange of Thailand. To find out more about Mega Lifesciences Public contact Vivek Dhawan at 66 2 769 4222 or learn more at https://www.megawecare.com.Mega Lifesciences Public Investment Alerts
| Mega Lifesciences generated a negative expected return over the last 90 days | |
| About 61.0% of the company outstanding shares are owned by corporate insiders |
Mega Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 42.72 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mega Lifesciences's market, we take the total number of its shares issued and multiply it by Mega Lifesciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Mega Profitablity
Mega Lifesciences' profitability indicators refer to fundamental financial ratios that showcase Mega Lifesciences' ability to generate income relative to its revenue or operating costs. If, let's say, Mega Lifesciences is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Mega Lifesciences' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Mega Lifesciences' profitability requires more research than a typical breakdown of Mega Lifesciences' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17. Technical Drivers
As of the 3rd of December, Mega Lifesciences secures the Mean Deviation of 1.3, risk adjusted performance of (0.04), and Standard Deviation of 1.78. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mega Lifesciences Public, as well as the relationship between them.Mega Lifesciences Public Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Mega Lifesciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Mega Lifesciences Public. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Mega Lifesciences Outstanding Bonds
Mega Lifesciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Mega Lifesciences Public uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Mega bonds can be classified according to their maturity, which is the date when Mega Lifesciences Public has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Mega Lifesciences Predictive Daily Indicators
Mega Lifesciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mega Lifesciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Mega Lifesciences Forecast Models
Mega Lifesciences' time-series forecasting models are one of many Mega Lifesciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mega Lifesciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Mega Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Mega Lifesciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mega shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mega Lifesciences. By using and applying Mega Stock analysis, traders can create a robust methodology for identifying Mega entry and exit points for their positions.
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures, markets, and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast moving consumer goods. Mega Lifesciences Public Company Limited is a subsidiary of Unistretch Limited. MEGA LIFESCIENCES operates under Drug Manufacturers - Major classification in Thailand and is traded on Stock Exchange of Thailand.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Mega Lifesciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
Other Information on Investing in Mega Stock
Mega Lifesciences financial ratios help investors to determine whether Mega Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mega with respect to the benefits of owning Mega Lifesciences security.